Detalhe da pesquisa
1.
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
N Engl J Med
; 386(26): 2482-2494, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657079
2.
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL).
Br J Haematol
; 193(2): 280-289, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33476434
3.
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.
Haematologica
; 104(11): 2241-2248, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31666344
4.
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience.
Ann Hematol
; 97(9): 1619-1626, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29663029
5.
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program.
Blood
; 122(23): 3759-66, 2013 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24085766
6.
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi.
Am J Hematol
; 90(1): 56-61, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25327841
7.
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi.
Front Oncol
; 13: 1120967, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36969038
8.
Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13).
EClinicalMedicine
; 64: 102221, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37781158
9.
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial.
Blood Adv
; 7(14): 3764-3774, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058477
10.
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.
Leukemia
; 37(2): 433-440, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36653509
11.
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma.
EJHaem
; 3(2): 394-405, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846031
12.
Phase Ib study of combinations of avadomide (CC-122), CC-223, CC-292, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma.
EJHaem
; 3(1): 139-153, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846221
13.
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study.
J Clin Oncol
; 40(7): 729-739, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34709880
14.
Efficacy of low-dose radiotherapy (2 Gy × 2) in the treatment of marginal zone and mucosa-associated lymphoid tissue lymphomas.
Br J Radiol
; 94(1123): 20210012, 2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34111959
15.
Real Life Use of Bendamustine in Elderly Patients with Lymphoid Neoplasia.
J Pers Med
; 11(4)2021 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33808164
16.
COVID-19 and Aspiration Pneumonia: Similar Pulmonary Findings with Different Diagnoses-a Pitfall in [18F]FDG PET/CT.
SN Compr Clin Med
; 3(11): 2322-2325, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34345767
17.
Follicular Lymphoma: The Management of Elderly Patient.
Mediterr J Hematol Infect Dis
; 9(1): e2017009, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28105297
18.
Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL).
Thromb Haemost
; 2017 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28447710
19.
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial.
Haematologica
; 90(6): 793-801, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15951292
20.
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial.
Clin Cancer Res
; 20(24): 6398-405, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25316810